Advertisements


We are Sorry, This Page doesn't Exist


Amgen partner AstraZeneca submits BLA for asthma candidate to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 10th, 2021

Theravance Biopharma Stock Is Believed To Be Modestly Undervalued

Related Stocks: TBPH,.....»»

Category: dealsSource: nytMay 1st, 2021

Scopus BioPharma submits IND to FDA for lead cancer drug candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 26th, 2021

Teleflex submits BLA to FDA for investigational freeze dried plasma candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 24th, 2021

Johnson & Johnson submits its COVID-19 vaccine candidate to WHO for emergency use

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 19th, 2021

Janssen submits for EUL to WHO for single-shot COVID vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2021

Johnson & Johnson submits application for COVID vaccine candidate to FDA

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchFeb 4th, 2021

Hedge Funds Have Never Been Less Bullish On Theravance Biopharma Inc (TBPH)

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Amo.....»»

Category: topSource: insidermonkeyDec 22nd, 2019

Theravance Biopharma (TBPH) Shares Cross Above 200 DMA

Market News Video.....»»

Category: topSource: redinewsNov 27th, 2019

BioMarin submits MAA in Europe for hemophilia A candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 21st, 2019

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2019 - Earnings Call Transcript

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q3 2019 - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 9th, 2019

Here is What Hedge Funds Think About Theravance Biopharma Inc (TBPH)

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Fa.....»»

Category: topSource: insidermonkeyOct 28th, 2019

Theravance Biopharma is Now Oversold (TBPH)

Dividend Channel.....»»

Category: topSource: redinewsSep 30th, 2019

Theravance Biopharma Breaks Above 200-Day Moving Average - Bullish for TBPH

Market News Video.....»»

Category: topSource: redinewsSep 10th, 2019

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q2 2019 Results - Earnings Call Transcript

Theravance Biopharma, Inc. (TBPH) CEO Rick Winningham on Q2 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 1st, 2019

Oversold Conditions For Theravance Biopharma (TBPH)

Legendary investor Warren Buffett ad.....»»

Category: futuresSource: nasdaqMay 20th, 2019

Theravance, Mylan study highlights possible role of Yupelri in COPD treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 20th, 2019

Theravance (TBPH) Q1 Loss Widens, Revenues Miss Estimates

Theravance Biopharma (TBPH) retains its earlier issued guidance for 2019 operating loss sans non-cash share-based compensation in.....»»

Category: personnelSource: nytMay 8th, 2019

Celgene (CELG) Submits NDA for MS Drug to FDA for Review

Celgene (CELG) progresses with the development of its MS candidate, as it submits an application.....»»

Category: worldSource: nytMar 26th, 2019

Theravance (TBPH) Starts Dosing in Ulcerative Colitis Study

Theravance (TBPH) commences phase IIb/III study for its gut-selective pan- JAK inhibitor, TD-1473 in patients with moderately .....»»

Category: dealsSource: nytMar 13th, 2019